 Connection
Linda Zittleman to Buprenorphine
This is a "connection" page, showing publications Linda Zittleman has written about Buprenorphine.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.468 |
|
|
|
-
Fernald DH, Nease DE, Westfall JM, Kwan BM, Dickinson LM, Sofie B, Lutgen C, Carroll JK, Wolff D, Heeren L, Felzien M, Zittleman L. A randomized, parallel group, pragmatic comparative-effectiveness trial comparing medication-assisted treatment induction methods in primary care practices: The HOMER study protocol. PLoS One. 2023; 18(9):e0290388.
Score: 0.699
-
Zittleman L, Curcija K, Nease DE, Fisher M, Miriam Dickinson L, Thomas JF, Espinoza A, Sutter C, Ancona J, Holtrop JS, Westfall JM. Increasing Capacity for Treatment of Opioid Use Disorder in Rural Primary Care Practices. Ann Fam Med. 2022 Jan-Feb; 20(1):18-23.
Score: 0.622
-
Cole ES, DiDomenico E, Green S, Heil SKR, Hilliard T, Mossburg SE, Sussman AL, Warwick J, Westfall JM, Zittleman L, Salvador JG. The who, the what, and the how: A description of strategies and lessons learned to expand access to medications for opioid use disorder in rural America. Subst Abus. 2021; 42(2):123-129.
Score: 0.147
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|